Suresh Emmanuel Joel1, Roberto Garcia Alvarez2, Juan Bachiller Egea3, Lucia Gonzalez Cortijo4, Vincente Martinez de Vega3, Rakesh Mullick1, and Mar Jimenez de la Pena3
1General Electric Global Research, Bangalore, India, 2General Electric Healthcare, Madrid, Spain, 3Departamento Diagnostico por la imagen, Hospital Universitario Quiron, Madrid, Spain, 4Departamento de Oncología Médica, Hospital Universitario Quiron, Madrid, Spain
Synopsis
More than three-fourth of chemotherapy treated cancer survivors have
cognitive impairment, including memory loss, inability to think, lasting
several years after completion of therapy, sometimes labelled as ‘chemobrain’.
Previously, the default mode network (DMN) has been shown to be specifically
vulnerable to chemotherapy. In this study we study changes in DMN connectivity
after chemotherapy within the same patients. In healthy adults, the DMN is
anti-correlated to task positive networks. We observe an increase in this
anti-correlation between DMN regions and task positive network regions
post-chemotherapy.Introduction
More than three-fourth of chemotherapy treated cancer survivors have cognitive
impairment, including memory loss, inability to think, lasting several years after
completion of therapy
1,2. There is also evidence of higher risk of
dementia among chemotherapy treated cancer survivors
3. Recently, functional neuroimaging has played
an important role in unraveling the complex underpinnings of this cognitive decline
associated with chemotherapy, sometimes labelled as ‘chemobrain’
4. Default mode network (DMN) is a functional
brain network that deactivates during high cognitive demand tasks and activates
during “rest”
5. The regions in the DMN have been found to be
critical hubs that connect several networks of the brain. DMN has been
implicated to change in several brain disorders. Further study of DMN in
chemotherapy-induced cognitive decline could aid in development and improvement
of therapy. DMN has been shown to be specifically vulnerable to chemotherapy
6,7. DMN connectivity has been shown to be
disrupted following chemotherapy
8 and DMN connectivity features were found to
contribute significantly to classify chemotherapy patients from
non-chemotherapy patients
7. Changes in DMN post-chemotherapy with baseline
measurement prior to chemotherapy has been suggested, but the authors are
unaware of any report on longitudinal changes in resting state functional
connectivity of the DMN. In this study we study changes in DMN connectivity
after chemotherapy within the same patients.
Methods & Materials
After obtaining informed consent, resting state
fMRI scans were acquired from six pre-menopause breast cancer patients prior to
and after (3 months to 1 year after initial scan) chemotherapy treatment.
Resting state fMRI was performed on a 3T Signa HDxt MR scanner (GE Healthcare,
Waukesha, WI) using an eight-channel phased array brain coil for 7 minutes with
TR/TE of 2000/30 ms, whole brain coverage, voxel dimensions of 1.875 x 1.875 x
5.5 mm. Data from one subject was noisy and hence excluded from analysis. In
all but two sessions, two rs-fMRI scans were acquired equivalent to 14 minutes
of data. T1-weighted image was also obtained for spatial normalization
purposes. The rs-fMRI data acquired were motion corrected, rigidly registered
to the T1-weighted image, non-rigidly registered to MNI atlas, nuisance
corrected using aCompCor
9 including removal of global signal, spatially
smoothed with a Gaussian of FWHM 4 mm and temporally filtered to pass between
0.01 and 0.1 Hz using in-house custom built software. Functional connectivity
map of the default mode network was extracted using correlation with a seed
region of 6 mm radius in the posterior cingulate cortex
10. The difference in connectivity estimates
(post-chemotherapy minus pre-chemotherapy) was computed and tested for
statistically significant (p<0.05 after multiple comparison correction)
change.
Results
Typical DMN was observed (as shown in Figure 1) in
pre-chemotherapy patients with PCC connections to bilateral inferior parietal
lobules, ACC, medial temporal lobes and posterior cerebellum. Group average of
DMN is shown in Figure 2 with typical regions with no visible difference in
connectivity. Within each subject the difference between post and
pre-chemotherapy showed significantly increased connectivity of the PCC to
bilateral hippocampus and the thalamus (Red-yellow regions in Figure 2). Significant
connectivity decrease in correlation to task positive networks were observed (blue
regions in Figure 3). This decrease in correlation is actually an increase in
anti-correlation post-chemotherapy.
Discussions & Conclusions
Memory related problems are the most frequently
reported cognitive impairment following chemotherapy
1. The DMN has been previously shown to be specifically
involved in chemotherapy related changes in cognition. The DMN is also functionally
connected to the hippocampus
10, a region strongly associated with memory. Increased
connectivity with bilateral hippocampus may be associated with the memory
impairments due to chemotherapy. The dorsal attention network which includes
the intra-parietal sulcus and the DMN are typically anti-correlated with each
other and is claimed to be competitive networks
11. The degree of anti-correlation has been shown
to be related to behavioral characteristics
12 including autistic traits and vigilance. Here
we observe an increase in the anti-correlation, which probably reflects an
increased level of vigilance. The increased anti-correlation could also be a
compensatory effect to the cognitive decline. Future directions include validating
this in larger data and associating the connectivity differences to
psychometric scores related to specific cognitive functions.
Acknowledgements
No acknowledgement found.References
1. Wefel, J. S. & Schagen, S. B.
Chemotherapy-related cognitive dysfunction. Curr. Neurol. Neurosci. Rep.
12, 267–275 (2012).
2. Pomykala, K. L., de Ruiter, M. B.,
Deprez, S., McDonald, B. C. & Silverman, D. H. S. Integrating imaging
findings in evaluating the post-chemotherapy brain. Brain Imaging Behav.
7, 436–452 (2013).
3. Heck, J. E., Albert, S. M., Franco, R.
& Gorin, S. S. Patterns of dementia diagnosis in surveillance,
epidemiology, and end results breast cancer survivors who use chemotherapy. J.
Am. Geriatr. Soc. 56, 1687–1692 (2008).
4. Scherling, C. S. & Smith, A.
Opening up the window into ‘chemobrain’: a neuroimaging review. Sensors 13,
3169–3203 (2013).
5. Raichle, M. E. et al. A default
mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 98,
676–682 (2001).
6. Dumas, J.
A. et al. Chemotherapy altered brain functional
connectivity in women with breast cancer: a pilot study. Brain Imaging
Behav. 7, 524–532 (2013).
7. Kesler, S. R. et al. Default
mode network connectivity distinguishes chemotherapy-treated breast cancer
survivors from controls. Proc. Natl. Acad. Sci. U. S. A. 110,
11600–11605 (2013).
8. Kesler, S. R. Default mode network as a
potential biomarker of chemotherapy-related brain injury. Neurobiol. Aging
35, Supplement 2, S11–S19 (2014).
9. Behzadi, Y., Restom, K., Liau, J. &
Liu, T. T. A component based noise correction method (CompCor) for BOLD and
perfusion based fMRI. NeuroImage 37, 90–101 (2007).
10. De Luca, M., Beckmann, C. F., De Stefano,
N., Matthews, P. M. & Smith, S. M. fMRI resting state networks define
distinct modes of long-distance interactions in the human brain. NeuroImage
29, 1359–1367 (2006).
11. Fox, M. D. et al. The human brain
is intrinsically organized into dynamic, anticorrelated functional networks. Proc.
Natl. Acad. Sci. U. S. A. 102, 9673–9678 (2005).
12. Kelly, A. M. C., Uddin, L. Q., Biswal, B.
B., Castellanos, F. X. & Milham, M. P. Competition between functional brain
networks mediates behavioral variability. NeuroImage 39, 527–537
(2008).